Transgenic animals expressing BGL3 were resistant to the Bcr-Abl-induced transformation of primary bone marrow, indicating that BGL3 is a tumor suppressor in CML.568. This evidence concerns the gene BGLT3 and chronic myelogenous leukemia, BCR-ABL1 positive.